Bringing the fundamentals into focus…
Back to Maze Therapeutics, Inc.
How Maze Therapeutics, Inc. stacks up
MAZE · against 421 other Healthcare companies of similar size
Overall
42/ 100
Below the middle of the pack.
Ranked #285 of 422 · scores higher than 30% of peers
Bars: peers in each 10-point band of the overall score73 peers with an overall score of 40–49, including MAZE · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around MAZE| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 285 | 3.1B EUR (≈$3.4B) | 42 | 67 | 25 | 63 | 2 / 2 | |
| 285 | 1.2B USD | 42 | 40 | 65 | 41 | 2 / 2 | |
| 285 | 1.4B USD | 42 | 68 | 28 | 52 | 2 / 2 | |
| 285 | 987M CHF (≈$1.1B) | 42 | 6 | 34 | 0 / 2 | ||
| 285 | 1.8B USD | 42 | 8 | — | 20 | 0 / 2 | |
| 285 | 1.9B NZD (≈$1.1B) | 42 | 32 | 62 | 33 | 1 / 2 | |
| 285 | 2.0B USD | 42 | 8 | — | 24 | 0 / 2 | |
| 285 | 1.9B USD | 42 | 8 | 86 | 18 | 1 / 2 | |
| 285 | 15.6B SEK (≈$1.6B) | 42 | 47 | 25 | 64 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score